+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Apellis Pharmaceuticals - logo

Apellis Pharmaceutical was founded in 2009 in Crestwood, U.S.A. It is a company with the aim of innovating and creating products to treat autoimmune and inflammatory diseases. Our lead compounds are designed to broadly inhibit complement C3, which is the central protein in the complement system.The complement system plays a key role in a wide range of autoimmune and inflammatory diseases. They believe with the use of C3 inhibition it may correct the immunological dysfunction. The approach they apply to this process is known as complement immunotherapy.

Artificial Intelligence (AI) in Clinical Trials Global Market Report 2024 - Product Thumbnail Image

Artificial Intelligence (AI) in Clinical Trials Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Geographic Atrophy (GA) - Pipeline Insight, 2024 - Product Thumbnail Image

Geographic Atrophy (GA) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Complement 3 Glomerulopathy Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Complement 3 Glomerulopathy Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 138 Pages
  • Global
From
Immune Complex Membranoproliferative Glomerulonephritis (IC - MPGN) - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Immune Complex Membranoproliferative Glomerulonephritis (IC - MPGN) - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2024
  • 99 Pages
  • Global
From
IgA Nephropathy Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

IgA Nephropathy Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • February 2022
  • 131 Pages
  • Global
From
Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 242 Pages
  • Global
From
Complement 3 Glomerulopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Complement 3 Glomerulopathy - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Wearable Injectors Global Market Report 2024 - Product Thumbnail Image

Wearable Injectors Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Autoimmune Treatment Global Market Report 2024 - Product Thumbnail Image

Autoimmune Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Asia Pacific Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 125 Pages
  • Asia Pacific
From
Europe Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 126 Pages
  • Europe
From
LAMEA Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 126 Pages
  • Africa, Middle East
From
North America Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 116 Pages
  • North America
From
IGA Nephropathy Disease Treatment Market - Forecast 2021 to 2026 - Product Thumbnail Image

IGA Nephropathy Disease Treatment Market - Forecast 2021 to 2026

  • Report
  • January 2022
  • 122 Pages
  • Global
From
Age-Related Macular Degeneration - Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Age-Related Macular Degeneration - Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2023
  • 115 Pages
  • Global
From
Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology And Market Forecast - 2034 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology And Market Forecast - 2034

  • Report
  • August 2024
  • 267 Pages
  • Global
From
Amyotrophic Lateral Sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Geographic Atrophy (GA) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Geographic Atrophy (GA) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Complement C3 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C3 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator